# NEXT-ChemX Corporation. > Clarifo company profile — qualitative business description generated from > the company's filings. Financial statements, charts and ratios are > available on Clarifo (https://www.clarifo.com/fi/companies/NEXT-ChemX Corporation.). ## Overview NEXT-ChemX Corporation is a U.S.-based development-stage chemical technology company focused on its membrane-based ion extraction process, known as iTDE Technology. The company was organized in Nevada and is developing modular systems intended to extract specific ions from liquid solutions for industrial and environmental applications. ## Products & services • iTDE membrane-based ion extraction technology • Pilot plant design and testing services • Modular extraction system prototypes • Commercial testing and deployment of extraction systems • Ion recovery solutions for brines, leachates, and waste streams - **iTDE Technology** (0%) — Membrane-based ion extraction systems used to selectively remove ions from liquid solutions. - **Pilot Plant Development** (0%) — Engineering, fabrication, and testing of pilot-scale extraction systems. - **Commercial Deployment** (0%) — Future sale or licensing of commercial extraction systems and related services. - iTDE membrane-based ion extraction technology - Pilot plant design and testing services - Modular extraction system prototypes - Commercial testing and deployment of extraction systems - Ion recovery solutions for brines, leachates, and waste streams ## Customers The company’s target customers are industrial users that need selective ion extraction from brines, mine leach solutions, process water, or waste streams. Its technology is also relevant to users seeking lower-energy separation methods for lithium, metals, salts, and other dissolved materials. - **Brine and lithium operators** (primary) — Buy or evaluate ion extraction systems for lithium-bearing brines and similar solutions. - **Mining and metal recovery customers** (primary) — Use the technology to extract specific metal ions from mine leach solutions and effluents. - **Industrial process users** (secondary) — Seek separation and purification tools for oils, biodiesel, and other process streams. - **Environmental and waste-treatment users** (secondary) — Need selective removal of salts, radioactive ions, or contaminants from wastewater. - Brine processors seeking lithium or salt extraction - Mining and metallurgical operators with leach solutions - Industrial users needing selective ion removal - Environmental and waste-treatment operators - Potential licensees or evaluators of the iTDE system ## Geography NEXT-ChemX is incorporated and headquartered in Las Vegas, Nevada, with principal offices in the United States. Its pilot plant work is underway in India, indicating that development and testing activities are not limited to its U.S. base. - **United States** (100%) — Corporate domicile and principal office - **India** (0%) — Pilot plant development location - Incorporated in Nevada and based in Las Vegas, USA - Principal office in Summerlin South, Las Vegas - Pilot plants currently underway in India - Commercial rollout may depend on pilot results and site readiness - Geographic footprint is tied to testing, not broad operating scale ## Strategy The company’s near-term strategy is to complete pilot plants, demonstrate extraction economics, and convert technical validation into commercial testing with potential users. Longer term, it aims to scale the modular iTDE system and move toward an initial production facility and broader deployment. - **Complete pilot plant trials** (short-term) — Technical validation is needed before commercial adoption and customer testing. - **Demonstrate commercial extraction economics** (short-term) — Customers need proof that the process is viable versus alternative separation methods. - **Scale modular deployment** (medium-term) — The modular architecture is intended to increase capacity by adding units. - Complete pilot plants to validate the extraction process - Demonstrate economics to potential industrial users - Advance from laboratory testing to commercial trials - Scale through modular system design - Prepare for initial production facility and deployment ## Risks NEXT-ChemX faces development-stage execution risk because its business depends on successful pilot testing, customer validation, and eventual commercialization of a novel process. It also faces financing risk, customer adoption risk, and technical scale-up risk, while broader chemical and industrial markets expose it to regulation, competition, and project delays. - **Pilot plant and commercialization execution risk** [high] — The company must complete testing, calibration, and validation before it can sell at scale. - **Financing and liquidity risk** [high] — Development activities require ongoing capital and the company has relied on shareholder support. - **Technology adoption risk** [high] — Potential customers may not adopt the system until performance and economics are proven. - **Scale-up and technical performance risk** [medium] — A modular lab-tested process may behave differently in larger or customer-specific settings. - **Regulatory and environmental risk** [medium] — Industrial extraction and wastewater applications are subject to environmental and local rules. - Pilot plant delays could postpone commercialization - Customer adoption depends on proving extraction economics - Funding needs may exceed available working capital - Scale-up risk is high for a novel membrane process - Regulatory and environmental compliance can affect deployment ## Accounting As a development-stage company with no reported revenue, NEXT-ChemX’s accounting is driven by capitalized or expensed development activities, pilot plant costs, and management estimates. Investors should watch how the company accounts for equipment, materials, payroll, and any future intangible assets or impairment considerations as commercialization progresses. - **Development-stage expense recognition** — Operating results are highly sensitive to project spending - **Management estimates and assumptions** — Can materially affect reported assets and expenses - **Potential impairment of intangible assets** — Could affect future balance sheet values and earnings - **Going-concern and liquidity disclosures** — Important for assessing financial statement risk - No revenue yet, so results are driven by development spending - Pilot plant equipment and materials affect expense timing - Management estimates are important in a pre-revenue business - Future intangible asset or impairment judgments may become relevant - Going-concern and liquidity assumptions can affect disclosures --- *Last updated: 2026-04-29T04:39:55.343282+00:00*